Ilios Therapeutics Alternatives & Competitors
12 companies similar to Ilios Therapeutics — Neurodegenerative Disease Multi-target Platform
Companies similar to Ilios Therapeutics
Eikonizo Therapeutics
Envisioning an end to neurodegenerative diseases.
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
Kineta (Reverse Merger With Yumanity Therapeutics)
Pioneering new horizons in neurodegenerative disease treatment by addressing protein misfo...
Spinogenix, Inc.
Developing a new class of therapeutics for neurodegenerative and psychiatric diseases
Rival Readout
Competing with Ilios Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
PRAEVENTIX LLC
Pioneering the future of healthcare by developing innovative therapies for bowel, dermatol...
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Aurealis Therapeutics
Multi-target cell and gene therapies for unmet medical needs.
Octagon Therapeutics
Advancing antibiotic innovation for multi-drug resistant infections with a world-class tea...
Cleave Therapeutics, Inc.
VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
Alphyn Biologics, Inc.
Alphyn develops first-in-class, multi-target therapeutics for atopic dermatitis & other se...
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ilios Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.